Publication | Pharmaceutical Compliance Monitor

Recent Trends in Whistleblower Protection under Dodd–Frank

Edward Buthusiem and Gary Miller

October 20, 2014

Edward Buthusiem and Gary Miller discuss how pharmaceutical and medical device manufacturers should stay up to date with Dodd–Frank Act and SEC and DOJ fraud investigations and enforcement actions.


Related Professionals

Edward J. Buthusiem

Managing Director

Washington, DC